201 related articles for article (PubMed ID: 37394878)
1. The Impact of a History of Different Other Cancers on the Long-Term Outcomes of Patients with Gallbladder Cancer: A Propensity Score-Adjusted, Population-Based Study.
Wang J; Zhang C; Yan D
Technol Cancer Res Treat; 2023; 22():15330338231183937. PubMed ID: 37394878
[TBL] [Abstract][Full Text] [Related]
2. Impact of prior cancer history on survival in brain malignancy: A propensity score-adjusted, population-based study.
Ebad Ur Rehman M; Faraz F; Cheema HA; Ashruf OS; Raheel H; Naqvi SZA; Jabeen N; Abid A; Mumtaz Malik H; Iftikhar A; Ibrahim A; Swed S
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1984. PubMed ID: 38389401
[TBL] [Abstract][Full Text] [Related]
3. Impact of Prior Cancer History on the Clinical Outcomes in Advanced Breast Cancer: A Propensity Score-Adjusted, Population-Based Study.
Lin C; Wu J; Ding S; Goh C; Andriani L; Shen K; Zhu L
Cancer Res Treat; 2020 Apr; 52(2):552-562. PubMed ID: 31801318
[TBL] [Abstract][Full Text] [Related]
4. Treatment of advanced gallbladder cancer: A SEER-based study.
Mao W; Deng F; Wang D; Gao L; Shi X
Cancer Med; 2020 Jan; 9(1):141-150. PubMed ID: 31721465
[TBL] [Abstract][Full Text] [Related]
5. The impact of pre-existing cancer on survival of prostate cancer patients: A population-based study.
Zhou Y; Guan H; Fu Y; Mao L; Ge J; Liu L; Cheng L; Guan C
Medicine (Baltimore); 2018 Dec; 97(50):e13479. PubMed ID: 30558003
[TBL] [Abstract][Full Text] [Related]
6. Effect of prior cancer history on survival of patients with esophageal carcinoma: a propensity score matching, population-based study.
Liu J; Chen Y; Zhan X; Yu Y; Yao H
J Thorac Dis; 2022 Apr; 14(4):979-994. PubMed ID: 35572868
[TBL] [Abstract][Full Text] [Related]
7. Survival analysis of patients with primary breast duct carcinoma and lung adenocarcinoma: a population-based study from SEER.
Lv F; Cheng M; Jiang L; Zhao X
Sci Rep; 2021 Jul; 11(1):14790. PubMed ID: 34285322
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of Hepatocellular Carcinoma Among Cancer Survivors with Other Types of Primary Tumors.
Bian X; He X; Yang L; Wu W; Li L
Dig Dis Sci; 2020 Jul; 65(7):2140-2147. PubMed ID: 31673904
[TBL] [Abstract][Full Text] [Related]
9. Impact of prior cancer history on the overall survival of patients newly diagnosed with cancer: A pan-cancer analysis of the SEER database.
Zhou H; Huang Y; Qiu Z; Zhao H; Fang W; Yang Y; Zhao Y; Hou X; Ma Y; Hong S; Zhou T; Zhang Y; Zhang L
Int J Cancer; 2018 Oct; 143(7):1569-1577. PubMed ID: 29667174
[TBL] [Abstract][Full Text] [Related]
10. Impact of prior cancer history on survival of patients with gastric cancer.
Wen L; Yu K; Lu H; Zhong G
Eur J Surg Oncol; 2021 Sep; 47(9):2286-2294. PubMed ID: 33632589
[TBL] [Abstract][Full Text] [Related]
11. Impact of prior cancer history on outcomes in thymoma: a propensity score, population-based study.
Wu S; Peng G; Liang W; He J
Gland Surg; 2021 May; 10(5):1618-1626. PubMed ID: 34164306
[TBL] [Abstract][Full Text] [Related]
12. Impact of prior cancer history on the survival of patients with larynx cancer.
Zhu K; Lin R; Zhang Z; Chen H; Rao X
BMC Cancer; 2020 Nov; 20(1):1137. PubMed ID: 33228622
[TBL] [Abstract][Full Text] [Related]
13. Impact of prior cancer on the overall survival of patients with nasopharyngeal carcinoma.
Wang X; Wang Z; Chen Y; Lin Q; Chen H; Lin Y; Lu L; Zheng P; Chen X
Am J Otolaryngol; 2022; 43(1):103235. PubMed ID: 34563802
[TBL] [Abstract][Full Text] [Related]
14. Does Prior Cancer Have an Influence on the Survival Outcomes of Patients with Localized Pancreatic Neuroendocrine Tumors?
Wang L; Li G; Bing YT; Tian ML; Wang HY; Yuan CH; Xiu DR
Chin Med Sci J; 2021 Dec; 36(4):284-294. PubMed ID: 34986965
[TBL] [Abstract][Full Text] [Related]
15. Comparison of prognostic and treatment between T1a and T1b glottic cancer: a propensity score-matched SEER database analysis.
Fang L; Tuohuti A; Shi L; Chen X
Eur Arch Otorhinolaryngol; 2023 Jul; 280(7):3313-3322. PubMed ID: 37039896
[TBL] [Abstract][Full Text] [Related]
16. Prior cancer does not adversely affect survival in locally advanced lung cancer: A national SEER-medicare analysis.
Laccetti AL; Pruitt SL; Xuan L; Halm EA; Gerber DE
Lung Cancer; 2016 Aug; 98():106-113. PubMed ID: 27393515
[TBL] [Abstract][Full Text] [Related]
17. Clinical features, treatment, and prognosis of different histological types of primary small bowel adenocarcinoma: A propensity score matching analysis based on the SEER database.
Zhou YW; Xia RL; Chen YY; Ma XL; Liu JY
Eur J Surg Oncol; 2021 Aug; 47(8):2108-2118. PubMed ID: 33849741
[TBL] [Abstract][Full Text] [Related]
18. Site-specific metastases of gallbladder adenocarcinoma and their prognostic value for survival: a SEER-based study.
Yang Y; Tu Z; Ye C; Cai H; Yang S; Chen X; Tu J
BMC Surg; 2021 Jan; 21(1):59. PubMed ID: 33485332
[TBL] [Abstract][Full Text] [Related]
19. A Propensity Score Analysis of Chemotherapy Use in Patients With Resectable Gallbladder Cancer.
Ozer M; Goksu SY; Sanford NN; Porembka M; Khurshid H; Ahn C; Maxwell MC; Beg MS; Kazmi SM
JAMA Netw Open; 2022 Feb; 5(2):e2146912. PubMed ID: 35171262
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of N1c in colorectal cancer: a large population-based study using propensity score matching.
Shen F; Hong X
Int J Colorectal Dis; 2019 Aug; 34(8):1375-1383. PubMed ID: 31201493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
